Jana Medical Company (TADAWUL:9616)

Saudi Arabia · Delayed Price · Currency is SAR

13.50

-0.69 (-4.86%)

Oct 1, 2025, 3:12 PM AST

Jana Medical Company Financials Overview

Financials in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	36.71	36.71	61.36	43.05
Revenue Growth	-42.94%	-40.18%	42.55%	-
Gross Profit	16.84	16.84	30.69	16.92
Operating Income	-5.24	-5.24	12.53	7.5
Net Income	-23.17	-23.17	5.41	5.22
Earnings Per Share	-8.74	-8.74	2.11	2.60
EPS Growth	-	-	-18.91%	-

Cash & Debt

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Investments	18.44	18.44	1.71	1.43
Total Debt	29.08	29.08	33.31	25.41
Net Cash (Debt)	-10.64	-10.64	-31.6	-23.98
Net Cash Growth	-	-	-	-
Net Cash Per Share	-4.01	-4.01	-12.29	-11.93

Cash Flow & CapEx

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Operating Cash Flow	5.33	5.33	-12.62	-36.41
Capital Expenditures	-0.01	-0.01	-0.16	-0.36
Free Cash Flow	5.32	5.32	-12.78	-36.77
Free Cash Flow Growth	-49.63%	-	-	-

Margins

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Gross Margin	45.89%	45.89%	50.02%	39.30%
Operating Margin	-14.28%	-14.28%	20.42%	17.43%
Pretax Margin	-59.26%	-59.26%	10.67%	12.92%
Profit Margin	-63.13%	-63.13%	8.82%	12.14%
FCF Margin	14.48%	14.48%	-20.82%	-85.42%

Valuation

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Jul '26 Jul 26, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
P/FCF Ratio	8.16	25.92	-	-
PS Ratio	1.18	3.75	-	-